Chemistry:Ontunisertib

From HandWiki

Ontunisertib is an investigational new drug that is being evaluated by Agomab Spain S.L.U. for the treatment of fibrostenotic Crohn's Disease. It is a TGF beta receptor 1 (ALK5) antagonist.[1][2]

References

  1. ↑ "Ontunisertib - AgomAb Therapeutics". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800064282. 
  2. ↑ "Anti-fibrotic therapy in Crohn's disease: hype or reality-can intestinal fibrosis be targeted effectively?". Expert Review of Gastroenterology & Hepatology: 1–5. June 2026. doi:10.1080/17474124.2026.2695461. PMID 42364152. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Ontunisertib&oldid=4583188"